Author

Garima Yagnik

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Aaron Diaz· 2 shared Alan Nguyen· 1 shared Ankush Chandra· 1 shared Aparna BhaduriiD· 1 shared Arman Jahangiri· 1 shared Beatriz AlvaradoiD· 1 shared Elizabeth Di LulloiD· 1 shared Gary Kohanbash· 1 shared

Activity by Year

2018-2018 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Aaron Diaz

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A draft single-cell atlas of human glioblastoma reveals a single axis of phenotype in tumor-propagating cells.

Sören Müller, Elizabeth Di Lullo, Aparna Bhaduri, Beatriz Alvarado, Garima Yagnik, Gary Kohanbash, Manish Aghi, Aaron Diaz

This study constructs a single-cell atlas of human glioblastoma, revealing a single axis of variation in tumor-propagating cells and linking mesenchymal GSCs to poor prognosis.

bioRxiv · Jul 26, 2018 · PreprintCancer Biology

A novel xenograft model reveals invasive mesenchymal transition and ineffective angiogenic response during anti-angiogenic therapy resistance

Arman Jahangiri, William Chen, Ankush Chandra, Alan Nguyen, Garima Yagnik, Jacob Weiss, Kayla J. Wolf, Jung-Ming G. Lin, Soeren Mueller, Jonathan Rick, Maxim Sidorov, Patrick Flanigan, W. Shawn Carbonell, Aaron Diaz, Luke Gilbert, , Manish K. Aghi

This study develops a xenograft model to study bevacizumab resistance in glioblastoma, finding increased mesenchymal markers and ineffective angiogenic responses across generations.

bioRxiv · Apr 12, 2018 · PreprintCancer Biology